Balanced Fund
How this report was made: what the research step did, which words are whose, and the fund's own figures as they were supplied. None of it appears in the document.
- Type
- Fund report
- Generated
- 07 Sep 2026, 11:46
- Period
- Month ended 31 August 2026
- Template
- Standard fund report
- Written for
- No reader profile recorded
- Drafted under
- No prompt guide
- Asked for as
- Word
- Sources
- 3
- Provenance
- Clean
Research run
No research run was recorded for this report. Either it was assembled from the fund's own figures without AI drafting, or it was generated before the run log existed.
Where each passage came from
The Sources list below answers "what does this source hold up". This is the same question from the other end: for a sentence you doubt, what is under it.
| Passage | Part of | Written by | Rests on |
|---|---|---|---|
| Interest rates | Macro driver | Written by a person | Investment Committee minutes, 1 September 2026 |
| Bond yields | Macro driver | Written by a person | Investment Committee minutes, 1 September 2026 |
| FX | Macro driver | Written by a person | Monthly valuation pack, August 2026 |
| Inflation | Macro driver | Written by a person | Investment Committee minutes, 1 September 2026 |
| Market commentary | Commentary | Written by a person | Investment Committee minutes, 1 September 2026 |
| Attribution commentary | Commentary | Written by a person | Performance attribution run, August 2026 |
| Outlook | Commentary | Written by a person | Investment Committee minutes, 1 September 2026 |
Fund figures, as supplied
The fund's own numbers, as the data source gave them to this run. Nothing here was written by a model. A country or holding table in the document is a reduction of what is below — the rows it does not name are still figures the report was built on, so they are kept here rather than dropped.
Returns 4 rows
Every row the data carries is named in the document.
| Period | Fund % | Benchmark % | Excess % |
|---|---|---|---|
| 1 Month | +1.30 | +1.10 | +0.20 |
| 3 Months | +3.20 | +3.40 | -0.20 |
| 1 Year | +9.60 | +8.80 | +0.80 |
| Since Inception | +7.40 | +6.90 | +0.50 |
Attribution by sector 5 rows
Every row the data carries is named in the document.
| Name | Allocation % | Selection % | Total effect % |
|---|---|---|---|
| Global Equities | +0.14 | +0.09 | +0.23 |
| NZ Fixed Interest | -0.03 | +0.05 | +0.02 |
| International Fixed Interest | +0.02 | -0.01 | +0.01 |
| Cash | +0.01 | +0.00 | +0.01 |
| Listed Property | -0.04 | +0.02 | -0.02 |
Positioning by sector 6 rows
Every row the data carries is named in the document.
| Name | Fund weight % | Benchmark weight % | Active weight % |
|---|---|---|---|
| Global Equities | +46.50 | +45.00 | +1.50 |
| NZ Fixed Interest | +18.20 | +20.00 | -1.80 |
| International Fixed Interest | +17.80 | +20.00 | -2.20 |
| Cash | +5.50 | +5.00 | +0.50 |
| Listed Property | +6.00 | +5.00 | +1.00 |
| Other | +6.00 | +5.00 | +1.00 |
What the report tells its reader
The figures in this report are fixed placeholder data and do not vary by period. Changing the reporting dates changes what the report says it covers, not the numbers in it.
Market reactions were drafted by an AI model, which searched NZX, ASX, Disclose Register, NZ Companies Office, Financial Markets Authority, Reserve Bank of New Zealand, Stats NZ, NZ Treasury, Bloomberg, BusinessDesk, National Business Review, interest.co.nz, US SEC EDGAR, US Federal Reserve, European Central Bank for Fisher & Paykel Healthcare, Auckland International Airport. Every resulting statement is labelled and footnoted to the source it came from.
Research failed for Fisher & Paykel Healthcare: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': "'claude-sonnet-5' does not support the `fallbacks` parameter."}, 'request_id': 'req_011Ceo5Rg1jAg59cXUnLbkgd'}
Research failed for Auckland International Airport: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': "'claude-sonnet-5' does not support the `fallbacks` parameter."}, 'request_id': 'req_011Ceo5RibkusxWCtrjKuBZf'}
Commentary drafting failed for Market commentary: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': "'claude-sonnet-5' does not support the `fallbacks` parameter."}, 'request_id': 'req_011Ceo5RkMRZ7UJbgyFN8oi2'}
Commentary drafting failed for Attribution commentary: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': "'claude-sonnet-5' does not support the `fallbacks` parameter."}, 'request_id': 'req_011Ceo5RnBZcBHCJ562vcPKE'}
Commentary drafting failed for Outlook: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': "'claude-sonnet-5' does not support the `fallbacks` parameter."}, 'request_id': 'req_011Ceo5RotVx9rGx4qLig357'}
